Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Committee Votes topic

No spam. Unsubscribe anytime.

Assembly committee advances a package of maternal and consumer-safety bills

Assembly Communities Development and Womens Affairs Committee · October 17, 2024
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Assembly Communities Development and Women—s Affairs Committee released A1799 (maternal health pilot/shared decision tool), A1973 (endometriosis screening with committee amendments), A2437 (menstrual product ingredient labeling, amended), and A3735 (creates crime of fertility fraud); all were released from committee by voice vote.

The Assembly Communities Development and Women—s Affairs Committee voted to release several bills affecting maternal and reproductive health and consumer labeling during its session.

A1799, which the committee read into the record, would require the Department of Health to develop a shared decision‑making tool and establish a maternal health care pilot program. There were no testifiers in opposition; Shadayah Bennett (Advocates for Children of New Jersey) was noted in favor without testifying. The committee moved and released the bill by unanimous voice vote.

A1973—aimed at screening certain pregnant persons and people who have given birth for endometriosis—was considered with committee amendments that delete a proposed refusal/acknowledgement form and move the bill—s effective date to 180 days after enactment. No outside testifiers appeared; the committee voted to amend and release the bill.

A2437, which would require menstrual-product ingredients to appear on packaging and be posted online, was released with committee amendments that give manufacturers 18 months after the effective date to comply. Ed Waters, senior director of government affairs for the Chemistry Council of New Jersey, testified that his organization supports the bill as amended and said the changes help manufacturers comply with federal law and align the state rule with similar California requirements: "we're happy to support this bill as amended." (Ed Waters, Chemistry Council of New Jersey)

A3735, which establishes a criminal offense for fertility fraud, had no testifiers and was released by unanimous voice vote.

All motions to release these bills passed on recorded affirmative responses from the members present. The committee indicated sponsors may continue to refine provisions, and multiple items were released with committee amendments to address drafting and implementation concerns.

The committee then moved to other items on the agenda.